Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients

Clinical trial NCT01448174 · COMPLETED

Trial details

NCT number: NCT01448174
Sponsor: Poznan University of Medical Sciences
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Renal Failure Chronic Requiring Hemodialysis Metabolic Syndrome Diabetes Mellitus Type 2 Hyperlipidemia

Start date: 2011-10-01
Primary completion: 2014-10-01
Enrollment: 310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.